Gsa Capital Partners LLP Heska Corp Transaction History

Gsa Capital Partners LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$60.21 - $77.74 $22,699 - $29,307	377 Added 5.0%	7,916 $492,000
Q3 2022 Nov 14, 2022	SELL	$72.92 - $99.73 $878,248 - $1.2 Million	-12,044 Reduced 61.5%	7,539 $550,000
Q2 2022 Aug 09, 2022	BUY	$84.23 - $147.57 $1.65 Million - $2.89 Million	19,583 New	19,583 $1.85 Million
Q3 2018 Nov 13, 2018	SELL	$97.14 - $113.31 $378,846 - $441,909	-3,900 Closed	0 $0
Q2 2018 Aug 09, 2018	SELL	$74.5 - $108.91 $1.05 Million - $1.54 Million	-14,105 Reduced 78.34%	3,900 $405,000
Q1 2018 May 11, 2018	BUY	$58.36 - $83.18 $676,976 - $964,888	11,600 Added 181.11%	18,005 $1.42 Million
Q4 2017 Feb 14, 2018	SELL	$77.49 - $98.41 $550,179 - $698,711	-7,100 Reduced 52.57%	6,405 $514,000
Q3 2017 Nov 20, 2017	BUY	$84.87 - $109.54 $1.15 Million - $1.48 Million	13,505	13,505 $1.19 Million

26K

Ticker HSKA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,818,900
Description
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.